Tepotinib

3-{1-[(3-{5-[(1-Methylpiperidin-4-yl)methoxy]pyrimidin-2-yl}phenyl)methyl]-6-oxo-1,6-dihydropyridazin-3-yl}benzonitril

Stoffgruppe

Antineoplastisches Mittel (Proteinkinase-Inhibitor)